18 years of pharmaceutical science

KEA LIFESCIENCE PRIVATE LIMITED

An Indian multinational pharmaceutical and biotechnology company headquartered in Hyderabad, integrating APIs, contract research, complex generics, formulations, biosimilars, exports, and healthcare access programs.

Corporate highlights
Founded
2008
Countries served
45+
Branch hubs
6
Manufacturing plants
4
APIs Biosimilars Manufacturing Global exports
Company overview

A vertically integrated healthcare enterprise

Since 2008, KEA Lifescience has grown from a single manufacturing unit into a company spanning the pharmaceutical value chain from active ingredients and contract research to finished formulations and biotechnology.

Pharmaceutical cleanroom operations
Bridge between Western research and affordable medicine for emerging economies.
Trusted partner for leading global generic pharmaceutical companies.
Operational network across Hyderabad, Mumbai, Delhi NCR, Bangalore, Chennai, and Kolkata.
Expansion focus across Latin American and African healthcare markets.
Featured portfolio

APIs, formulations, oncology, and biosimilars

A selected view of KEA Lifescience product programs.

Kea-Fen

Ibuprofen API

World-class anti-inflammatory API for regulated formulation programs.

Kea-Zole

Fluconazole API

High-yield antifungal API supported by process chemistry expertise.

Kea-Cape

Oncology API

Complex molecule program for oncology therapeutic development.

Kea-Tax

Oncology API

Specialized oncology API for advanced cancer-care formulations.

CardioKare

Atorvastatin + Aspirin

Cardiovascular-care fixed-dose combination formulation.

NeuroBalance SR

Pregabalin SR

Sustained-release formulation for neuropathic pain management.

GastroSafe-IT

Pantoprazole + Domperidone

Digestive-health formulation for gastro-care portfolios.

Kea-Insulin G

Recombinant human insulin analogue

Biotechnology portfolio launch focused on insulin access.

Kea-Mab

Trastuzumab biosimilar

Advanced biosimilar program for breast-cancer treatment access.

Milestones

An 18-year journey of growth and innovation

Major milestones from the company profile.

2008

Founded in a Hyderabad R&D lab with 12 employees.

2012

Launched first in-house oncology drug and received the ICICI Pharma Excellence Award.

2015

Opened Mumbai branch and started USFDA filing processes.

2017

Acquired Chennai formulation plant and crossed 200 global product registrations.

2019

Inaugurated Delhi NCR branch for policy advocacy and government tenders.

2021

Launched Bangalore Biotech R&D center and AI drug-discovery division.

2023

Opened Kolkata eastern hub and reached INR 2,500 crore annual turnover.

2025

Received Pharma Company of the Decade at the India Pharma Summit.

2026

Celebrating 18 years with biosimilar portfolio and expansion into Latin America and Africa.

Partner with KEA

For product, export, research, manufacturing, or institutional supply inquiries.

Share the therapeutic category, market, documentation requirements, volume, and timeline so the relevant team can respond.

Contact team